Immunophotonics Appoints Richard M. Levenson, M.D. to Board of Directors
SAINT LOUIS, MO, UNITED STATES, November 25, 2025 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on developing novel Immune-stimulating drugs to augment routine tumor destruction techniques, has announced …